Akero Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Akero Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Akero Therapeutics Inc
Rating: 1.47341675
Author: Trendlyne DVM scores

about

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NA...

47.30 1.08 (2.34%)

121.65% Gain from 52W Low

354.3K

XNAS Volume

XNAS 26 Sep, 2025 2:22 PM (EDT)

Not Eligible

Expensive Valuation

6.7 / 100

Technically Neutral

52.3 / 100

No estimates available

Akero Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Akero Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NA...

121.65% Gain from 52W Low

SWOT Analysis

Akero Therapeutics Inc Live Price Chart